Clinical Trials Directory

Trials / Completed

CompletedNCT03615209

Effect of Vagus Stimulation on Peripheral Glucose Metabolism

Effekte Der Transkutanen Aurikularen Vagus-Nervenstimulation (tVNS) Auf Die Postprandiale Stoffwechselregulation im Menschen

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
15 (actual)
Sponsor
University Hospital Tuebingen · Academic / Other
Sex
Male
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

Two important mechanisms play a major role in the pathogenesis of type 2 diabetes: insulin resistance of the target tissues and the impaired insulin secretion from pancreatic β-cells. Postprandial factors (such as insulin) are perceived by the human brain and induce signals that regulate glucose metabolism via the parasympathetic nervous system. Transcutaneous auricular vagus nerve stimulation (tVNS) can be used on the outer ear to stimulate the auricular branch of the vagus nerve in humans. Heart rate variability (HRV) in healthy people can be significantly increased via tVNS, indicating a shift from sympathetic activity to parasympathetic activity. The hypothesis is that this postprandial shift results in a change in peripheral glucose metabolism. In turn, the increased parasympathetic activity could potentially result in a change in postprandial insulin sensitivity or secretion. To test this hypothesis, this study investigates the effect of vagal stimulation versus sham stimulation on insulin sensitivity, on insulin secretion, glucose tolerance, resting energy expenditure, and on parasympathetic tone (analysis of heart rate variability).

Conditions

Interventions

TypeNameDescription
DEVICETransauricular vagus nerve stimulationStimulation will be performed for 150 minutes (throughout the entire OGTT).
DEVICETransauricular sham stimulationSham stimulation will be performed for 150 minutes (throughout the entire OGTT)

Timeline

Start date
2018-07-25
Primary completion
2018-12-01
Completion
2018-12-20
First posted
2018-08-03
Last updated
2019-01-10

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT03615209. Inclusion in this directory is not an endorsement.